Inhibition of exercise-induced asthma by different pharmacological pathways.
about
Beta₂-agonists for exercise-induced asthmaMast-cell stabilising agents to prevent exercise-induced bronchoconstrictionAnticholinergic therapy for chronic asthma in children over two years of ageExercise-induced bronchoconstriction as an expression of bronchial hyperreactivity: a study of its mechanisms in childrenChoices of therapy for exercise-induced asthma in children.Attenuation of propranolol-induced bronchoconstriction by frusemidePrevention of exercise induced asthma by inhaled salmeterol xinafoate.Dose-response study of sodium cromoglycate in exercise-induced asthma.Inhibition of the bronchial response to respiratory heat exchange by increasing doses of terbutaline sulphate.Attenuation of exercise induced asthma by local hyperthermia.Protective effect of drugs on histamine-induced asthmaSodium cromoglycate and ipratropium bromide in exercise-induced asthmaMultiple exercise and histamine challenge in asthmatic patientsEffect of an inhaled antihistamine on exercise-induced asthma.Cholinergic blockade in the prevention of exercise-induced asthma.Effects of exercise training on airway hyperreactivity in asthma: a systematic review and meta-analysis.Aerosolized medication in chronic asthmatic children.Cromolyn sodium: a review.Pharmacotherapy for exercise-induced asthma: allowing normal levels of activity and sport.Theophylline therapy.Exercise-induced asthma and the athlete.Hyperventilation-induced asthma: evidence for two mechanisms.Platelet activation during exercise induced asthma: effect of prophylaxis with cromoglycate and salbutamol.Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics.Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate.More on pharyngeal infections.Eicosanoid and muscarinic receptor blockade abolishes hyperventilation-induced bronchoconstriction.Bronchodilator effect of sodium cromoglycate and its clinical implications.
P2860
Q24197597-9B45EDEB-9FB3-481B-9396-CCDB98F519B4Q24247733-53128526-9BE0-45D1-B241-658398DC6911Q24247918-627BAAED-823A-48C7-AC8B-A87C7E905D95Q33603539-D100D07E-FAC7-427D-8810-01FCF1272D1CQ34291192-7C8A2275-677D-40D4-969E-1B5118539BAFQ35563200-7F758C86-A249-438C-877A-DA5A85064F83Q35627764-21E32757-C6A1-4DCB-A67D-2DB3784722A2Q36123441-6305FC61-4F2C-4F4C-9CAB-31B5EDA81C71Q36125054-5A1F9931-1BF8-4899-A37F-03008491A20DQ36264374-819F0D91-B47D-4150-9B9A-31D8AA351A25Q36445477-43B61644-1A41-4307-B3E5-5810CC8DAE2AQ36453616-FD024CB7-9F21-4AA2-A2B6-C3D515954841Q36461282-8B8272BE-BBE4-458C-BE3C-C0F3D372D6F2Q36464672-0767DBA5-9F29-479F-949C-8E28A323C922Q36464713-40D71DF1-1E1C-4CF5-B15B-7C3147844FCBQ38121023-591AAD97-6063-4DBD-BB3F-DA9487A8EF42Q39196488-5F8C4578-875C-420C-B427-D6989B19AC65Q39848185-C9BF2307-1738-4842-85A4-E92BF8D5F6FDQ39914397-7E6C4CFA-6EB7-40E5-98D7-1387EE35D0E3Q40119415-9CD2B8C5-E436-4A26-A922-E1529DFCE1B2Q40456748-E7953AE3-C2BB-44EA-86FF-C75338A86E03Q41119484-EC36BA3F-BC5B-41D8-92BC-CE93509ACA58Q41125085-4058DFF9-3F06-42FF-9685-97370FBC50CBQ41331562-8608B177-B83B-44F8-BCF8-1BC9C8A23402Q41873025-100FB6E1-F351-4909-9D2D-204617014FAFQ44062008-29B32FBA-0956-4B6A-9412-F79782B5F1F0Q54032103-474AD19F-3315-4EA3-B487-4C715023DEEFQ55101689-109235F4-8005-465A-91F4-2A3D5312384B
P2860
Inhibition of exercise-induced asthma by different pharmacological pathways.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Inhibition of exercise-induced asthma by different pharmacological pathways.
@en
type
label
Inhibition of exercise-induced asthma by different pharmacological pathways.
@en
prefLabel
Inhibition of exercise-induced asthma by different pharmacological pathways.
@en
P2860
P356
P1433
P1476
Inhibition of exercise-induced asthma by different pharmacological pathways.
@en
P2093
P2860
P304
P356
10.1136/THX.31.2.137
P407
P577
1976-04-01T00:00:00Z